Our news

An immunotherapy drug called ‘pembrolizumab’ has been shown to significantly reduce disease recurrence in patients with the most aggressive type of breast cancer, according to results from a phase III clinical trial led.

The North East London Health and Care Partnership’s careers programme – which includes Barts Health’s Healthcare Horizons - will receive £250,000 from the Mayor’s Academies Programme.

The first in an annual lecture series in memory of former St Bartholomew’s Hospital nurse Pam Hibbs will take place next month.

As pressures ease across our hospitals, the army support provided to our trust has been withdrawn.

We are incredibly proud of what we have achieved as a network over the last few years. We started out as three people in The Royal London Hospital, and have grown into a community of 200+ active members and allies across all sites.